← Back to Search

Resistance Exercise for Type 1 Diabetes

N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female with type 1 diabetes diagnosed for at least 1 year
At least 12 months since last menstrual period
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 minutes to 45 minutes, and from 45 minutes to 105 minutes
Awards & highlights

Study Summary

This trial will help researchers understand how different types of exercise affect blood sugar levels in post-menopausal women with type 1 diabetes, in order to design better exercise programs for this population.

Who is the study for?
This trial is for post-menopausal women with Type 1 Diabetes living near Edmonton, Alberta. They should have been diagnosed at least a year ago and not had a menstrual period in the last 12 months. Participants must be able to do resistance exercise but can't join if they have high blood pressure, cardiovascular disease history, are on certain medications, or have conditions affecting exercise ability.Check my eligibility
What is being tested?
The study tests how different resistance exercises affect blood sugar levels in participants. One group will do low resistance but high repetition weight lifting (3 sets of 15-20 reps), while another does moderate resistance and repetitions (3 sets of 8-10 reps). The goal is to see which method impacts blood glucose during and after exercise.See study design
What are the potential side effects?
Potential side effects may include an increased risk of hypoglycemia (low blood sugar) during or after exercising. This could lead to symptoms like shakiness, sweating, confusion, heart palpitations or even fainting.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman diagnosed with type 1 diabetes for over a year.
Select...
It has been over a year since my last menstrual period.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 to 6 hours post exercise, overnight post exercise (midnight to 6 am) and 24 hours post exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 to 6 hours post exercise, overnight post exercise (midnight to 6 am) and 24 hours post exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood glucose
Secondary outcome measures
Mean continuous glucose monitoring (CGM) glucose
carbohydrate supplementation
coefficient of variation (CV)
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment2 Interventions
All participants will be in a single arm that undergoes two separate interventions. These interventions will include a high repetition, low resistance protocol, and a moderate repetition, moderate intensity protocol.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,122 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies in this research endeavor?

"Data on clinicaltrials.gov suggests that this medical trial is open for recruitment and has been edited as recently as March 31st 2022. The study was first uploaded to the site on April 1st of 2021."

Answered by AI

Are individuals aged 25 or older being included in this research effort?

"This clinical trial only permits participants between the ages of 45 and 75. There are 218 trials that cater to those under 18, while 925 studies focus on individuals above 65."

Answered by AI

Is it feasible for me to participate in this clinical trial?

"With the intention of recruiting 15 women between 45 to 75 years-old diagnosed with type 1 diabetes mellitus, this trial has specific requirements. The applicants must be physically capable and willing to do resistance exercise, have an HbA1c lower than 10%, live near Edmonton/be able to attend University of Alberta laboratory sessions, and had their condition for a minimum of one year as well as experienced 12 months since last menstrual cycle."

Answered by AI

What is the maximum capacity of individuals that can participate in this medical research?

"Affirmative. According to the data available on clinicaltrials.gov, this medical study is currently accepting patients who meet its inclusion criteria. The trial was initially posted on April 1st 2022 and had its most recent edit made at the end of March 2021. This research project has a goal of recruiting 15 people across one location."

Answered by AI
~1 spots leftby May 2024